Display options
Cite
Macek P, Sanchez-Salas R, Cathelineau X. Re: High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer. Initial Outcomes of a United States Series. Eur Urol. 2020;79(4):554-555doi: 10.1016/j.eururo.2020.11.039.
Macek, P., Sanchez-Salas, R., & Cathelineau, X. (2021). Re: High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer. Initial Outcomes of a United States Series. European urology, 79(4), 554-555. https://doi.org/10.1016/j.eururo.2020.11.039
Macek, Petr, et al. "Re: High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer. Initial Outcomes of a United States Series." European urology vol. 79,4 (2021): 554-555. doi: https://doi.org/10.1016/j.eururo.2020.11.039
Macek P, Sanchez-Salas R, Cathelineau X. Re: High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer. Initial Outcomes of a United States Series. Eur Urol. 2021 Apr;79(4):554-555. doi: 10.1016/j.eururo.2020.11.039. Epub 2020 Dec 09. PMID: 33308906.
Copy Download .nbib Format: NLM
Share it on

Eur Urol. 2021 Apr;79(4):554-555. doi: 10.1016/j.eururo.2020.11.039. Epub 2020 Dec 09.

Re: High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer. Initial Outcomes of a United States Series.

European urology

Petr Macek, Rafael Sanchez-Salas, Xavier Cathelineau

Affiliations

  1. Department of Urology, Institut Montsouris and Université de Paris, Paris, France. Electronic address: [email protected].
  2. Department of Urology, Institut Montsouris and Université de Paris, Paris, France.

PMID: 33308906 DOI: 10.1016/j.eururo.2020.11.039

[No abstract available.]

MeSH terms

Publication Types